Elaine Wangsawidjaja

Elaine advises clients on a wide range of US law transactional matters. In particular, Elaine focuses on private placements, entitlement offers, NASDAQ listings and SEC filings by Australian companies.

Selected Experience

• Bionomics/Neuphoria on its re-domiciliation from Australia to Delaware with listing on Nasdaq
• Mesoblast on A$260 million placement with resale registration statement on Form F-3
• Goodman Group on A$4 billion placement
• Xero on A$1.85 billion placement
• Vulcan Energy on A$1 billion accelerated non renounceable entitlement offer and placement
• Ryman Healthcare on NZ$1 billion entitlement offer and placement
• AUB on A$400 million placement
• Spartan Resources on A$220 million placement
• Clarity Pharmaceuticals on A$203 million placement
• Austal on A$200 million placement
• Capricorn Metals on A$200 million placement
• EBOS on A$200 million placement
• Catalyst Metals on A$150 million placement
• Chimeric Develop Global on A$180 million placement
• betr Entertainment on A$130 million entitlement offer and placement
• IperionX on A$100 million placement
• WA1 Resources on A$100 million placement
• Virgin Australia on IPO
• Saluda Medical, Inc. on IPO
• BMC Minerals Ltd. on IPO